Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry

Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry

A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. While the world is striving for a treatment modality against SARS-CoV-2, our understanding about the virus entry mechanisms may help to design entry inhibitors, which may help to limit the virus spread...

Full description

Bibliographic Details
Main Authors: Rahul K. Suryawanshi, Chandrashekhar D. Patil, Raghuram Koganti, Sudhanshu Kumar Singh, Joshua M. Ames, Deepak Shukla
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Pathogens
Subjects:
SARS-CoV-2
pseudotyped virus
entry inhibitors
cationic peptide
heparan sulfate
Online Access:https://www.mdpi.com/2076-0817/10/7/803

Internet

https://www.mdpi.com/2076-0817/10/7/803

Similar Items